Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports
Jan 6 (Reuters) - Eli Lilly LLY.N is in advanced talks to buy Ventyx Biosciences VTYX.O for over $1 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. Shares of Ventyx were up 5.2%. (Reporting by Puyaan Singh in Bengaluru; Editing by Tasim Zahid) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on Ventyx Biosciences
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Deals of the day-Mergers and acquisitions